
This paper reviews the role of prostaglandins (PGs) in cancer. Specific topics of discussion include: (1) the potential use of PGs as tumor markers, (2) PG mediation of hypercalcemia of cancer, and (3) the use of PG synthesis inhibitors in cancer therapy.

